共 50 条
- [21] Late Safety and Efficacy of a Zotarolimus-Eluting Stent Compared with a Paclitaxel-Eluting Stent in Patients with De Novo Coronary Lesions: Three-Year Follow-up from the ENDEAVOR IV Trial AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 150D - 150D
- [22] Comparison of Zotarolimus-Eluting Stents With Sirolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization The ZEST (Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent with Sirolimus-Eluting and PacliTaxel-Eluting Stent for Coronary Lesions) Randomized Trial JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (15) : 1187 - 1195
- [25] Comparison of Resolute zotarolimus-eluting stent and Sirolimus-Eluting Stents in Patients with Long Coronary Artery Lesions: A Randomized LONG-DES IV Trial AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (07): : 108S - 108S
- [28] Efficacy and safety at 3 and 5 years in the Canadian multicenter, randomized, double-blind trial of the sirolimus-eluting stent in the treatment of patients with de novo coronary artery lesions (C-SIRIUS) AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 63L - 63L
- [29] IMPACT OF SHORT- VERSUS LONG-TERM DAPT IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PERCUTANEOUS INTERVENTION WITH ENDEAVOR ZOTAROLIMUS-ELUTING STENTS - A SUBANALYSIS OF THE LARGE, PROSPECTIVE, RANDOMIZED, MULTICENTER OPTIMIZE TRIAL JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1859 - A1859